News

Filter

51 to 60 of 468 results

Amgen working on alternative methods for Mapp's Ebola vaccine; Canada sends vaccine vials to WHO

Amgen working on alternative methods for Mapp's Ebola vaccine; Canada sends vaccine vials to WHO

20-10-2014

USA-based Amgen, the world’s leading independent biotech firm, has indicated that it plans to work…

AmgenAntibiotics and Infectious diseasesBiotechnologyCanadaHuman InterestProductionRegulationResearchUSAZMapp

New Zealand's PHARMAC funds four new medicines as part of major agreement with Novartis

New Zealand's PHARMAC funds four new medicines as part of major agreement with Novartis

20-10-2014

New Zealand's Pharmaceutical Managment Agency PHARMAC has agreed to fund four new medicines for which…

Antibiotics and Infectious diseasesCardio-vascularglycopyrroniumindacaterolNew ZealandNovartisOmalizumabPharmaceuticalRegulationRespiratory and PulmonaryTobramycin

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

14-10-2014

Global medical technology business Smith & Nephew has found its Phase III study of HP802-247, a living…

Antibiotics and Infectious diseasesBiotechnologyHP802-247ResearchSmith & NephewUK

Positive new findings for Astellas’ isavuconazole in mucormycosis

Positive new findings for Astellas’ isavuconazole in mucormycosis

08-10-2014

Japanese drug major Astellas Pharma says that isavuconazole demonstrated successful outcomes in the treatment…

Antibiotics and Infectious diseasesAstellas PharmaisavuconazoleJapanPharmaceuticalResearch

Actavis to acquire Durata Therapeutics for $675 million

Actavis to acquire Durata Therapeutics for $675 million

06-10-2014

In a move that takes it further out of its main generics business, Ireland-headquartered Actavis has…

ActavisAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsIrelandMergers & AcquisitionsPharmaceutical

EPIC Biotech conference: essential to prove comercial viability of propositions

EPIC Biotech conference: essential to prove comercial viability of propositions

03-10-2014

The key message from European Partnering and Investment Conference in biotech, held yesterday in London,…

Antibiotics and Infectious diseasesBiotechnologyBoehringer IngelheimCardio-vascularCNS DiseasesFinancialJohnson & JohnsonMerck SeronoOncologyResearch

Daiichi Sankyo seeks wider indication for Cravit in Japan

Daiichi Sankyo seeks wider indication for Cravit in Japan

03-10-2014

Japanese drug major Daiichi Sankyo has submitted a supplemental New Drug Application (sNDA) in Japan…

Antibiotics and Infectious diseasesCravitDaiichi SankyoJapanPharmaceuticalRegulation

Novartis and Janssen take top prizes at this year's UK Prix Galien

Novartis and Janssen take top prizes at this year's UK Prix Galien

03-10-2014

Swiss drug major Novartis and US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen…

Antibiotics and Infectious diseasesBexseroJanssenNovartisPharmaceuticalSirturoUK

Ebola vaccines could be available early 2015, says WHO

Ebola vaccines could be available early 2015, says WHO

02-10-2014

The World Health Organization has issued an assessment of the situation regarding two candidate Ebola…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalPharmaceuticalResearch

51 to 60 of 468 results

COMPANY SPOTLIGHT

Menarini

Back to top